| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 10/11/2006 | CN1845933A Specific glucocorticosteriod compound having anti-inflamatory activity |
| 10/11/2006 | CN1845723A Methods for the treatment of endometriosis |
| 10/11/2006 | CN1843463A Medicine for treating barrenness, irregular menses, painful menstruation, endocrine dyscrasia and osteoporosis |
| 10/11/2006 | CN1279054C Type I cytokine receptor TCCR |
| 10/11/2006 | CN1279044C Non-steroidal progesterone receptor modulators |
| 10/10/2006 | US7119198 beta-aryl-alpha-oxysubstituted alkylcarboxylic acids, usch as Ethyl (E/Z)-3-[4-[2-(phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxypropenoate, used as antilipemic or hypoglycemic agents |
| 10/10/2006 | US7119120 A 2-benzenesulfonylamino-N-benzyl-benzamides for treating hyperphosphatemia, urogential disorders |
| 10/10/2006 | US7119110 Method and composition for preventing or reducing the symptoms of insulin resistance syndrome |
| 10/10/2006 | US7119086 Affinity and selectivity for arginine-vasopressin and/or ocytocin receptors; synthesis |
| 10/10/2006 | US7119081 Also estrogen phosphonates, thiophosphonates, sulphonates, sulphonamides, and N-acylsulfamates |
| 10/10/2006 | CA2356391C Transdermal drug delivery system |
| 10/10/2006 | CA2262778C Conformationally constrained backbone cyclized somatostatin analogs |
| 10/10/2006 | CA2253407C Inorganic ion receptor-active compounds |
| 10/05/2006 | WO2006104791A1 O-desmethylvenlafaxine and bazedoxifene combination product and uses thereof |
| 10/05/2006 | US20060223803 Process for resolving aimines that are useful for the treatment of disorders associated with insulin resistance syndrome |
| 10/05/2006 | US20060222717 Agent for Preventing and Curing Pathologies States Associated with Endorphin Deficiency in Organism |
| 10/05/2006 | DE102005015128A1 Wafer enthaltend Steroidhormone Wafer containing steroid hormones |
| 10/05/2006 | CA2601898A1 O-desmethylvenlafaxine and bazedoxifene combination product and uses thereof |
| 10/05/2006 | CA2598892A1 Tablet containing steroid hormones |
| 10/04/2006 | EP1706114A1 Chemical inhibitors of soluble adenylyl cyclase (sac) |
| 10/04/2006 | EP1560589B1 Novel complexes of fatty acid esters of polyhydroxyalkanes and niacinamide |
| 10/04/2006 | EP1119361A4 Treatment of carcinomas using squalamine in combination with other anti-cancer agents or modalities |
| 10/04/2006 | CN1842530A Methanesulfonic acid salt of pyrazolopyrimidine compound, crystal thereof, and process for producing the same |
| 10/04/2006 | CN1839823A Compositions useful for the treatment of pathologies responding to the activation of ppar-gamma receptor |
| 10/04/2006 | CN1277840C Growth hormone releasing compound for treating tumor and inhibitor thereof |
| 10/03/2006 | US7115754 Pyrrolidine derivatives as oxytocin antagonists |
| 10/03/2006 | US7115752 Substituted cyclic compounds |
| 10/03/2006 | US7115739 Triazole compounds useful as protein kinase inhibitors |
| 10/03/2006 | US7115707 Amino acid sequences capable of facilitating penetration across a biological barrier |
| 10/03/2006 | US7115648 use for treating type 2 diabetes, insulin resistance, syndrome X, hyperinsulinaemia, hyperglucagonaemia, cardiac ischaemia and obesity |
| 10/03/2006 | US7115639 useful in the treatment and/or prevention of preterm labor, premature birth and dysmenorrhea; in particular, the present invention is related to pyrrolidine derivatives displaying a substantial modulatory, notably an antagonist activity of the oxytocin receptor |
| 10/03/2006 | US7115637 Inhibitors of p38 |
| 10/03/2006 | US7115634 4-aminopiperidine and their use as a medicine |
| 10/03/2006 | US7115630 Metabotropic glutamate receptor antagonists |
| 10/03/2006 | US7115623 1,8-Naphthyridin-2(1H)-one derivatives; antiasthmatic, antihistamine, and bronchodilator agents; nontoxic, side effect reduction |
| 10/03/2006 | US7115599 Guanylate cyclase stimulant; cardiovascular disorders; thrombosis; antiischemic agents; sexual disorders; antiinflammatory agents; central nervous system disorders |
| 10/03/2006 | US7115395 DNAs encoding guinea pig histamine receptors of the H4 subtype |
| 10/03/2006 | CA2489834C Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
| 10/03/2006 | CA2346438C Utilisation of dialkylfumarates for treating host-versus-graft reactions and auto-immune diseases |
| 10/03/2006 | CA2288046C Intravaginal drug delivery devices for the administration of testosterone and testosterone precursors |
| 09/28/2006 | WO2006100557A1 Substituted triazole derivatives as oxytocin antagonists |
| 09/28/2006 | US20060217353 24-sulfoximine vitamin D3 compounds |
| 09/28/2006 | US20060217313 5-CNAC as oral delivery agent for parathyroid hormone fragments |
| 09/28/2006 | US20060216739 Insulin-like growth factor binding protein |
| 09/28/2006 | US20060216277 Insulin-producing bone marrow derived cells and methods of generating and using same |
| 09/27/2006 | EP1705179A1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 09/27/2006 | EP1705174A1 Selective androgen receptor modulators and methods of use thereof |
| 09/27/2006 | EP1705169A2 Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 09/27/2006 | EP1560575B1 3,5,3'-triiodothyronine sulfate as thyromimetic agent and pharmaceutical formulations thereof |
| 09/27/2006 | EP1534687B1 2-phenylamino-4-trifluoromethyl-5-(benzyl- or pyridin-4-ylmethyl)carbamoylpyrimidine derivatives as selective cb2 cannabinoid receptor modulators |
| 09/27/2006 | EP1303537B1 Ho-1 suppressor as a diagnostic and prognostic test for dementing diseases |
| 09/27/2006 | EP0957921B1 17alpha-dihydroequilenin for preventing neurodegeneration and cognitive dysfunction |
| 09/27/2006 | EP0889733B1 Stabilised growth hormone formulation and method of preparation thereof |
| 09/27/2006 | CN1837205A Process for the preparation of pyrazolopyridine tartrates |
| 09/27/2006 | CN1276970C New strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it |
| 09/27/2006 | CN1276969C Liquor prepared from traditional medicine and process for its preparation |
| 09/27/2006 | CN1276748C Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation |
| 09/26/2006 | US7112607 Antihypoxic agents, antiischamic agents, antiarrhythmia agents |
| 09/26/2006 | US7112597 5-(Substituted thiazolylethoxy)indaneacetic acid derivatives, used in the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases |
| 09/26/2006 | US7112562 Insulin conjugates and methods of use thereof |
| 09/24/2006 | CA2539281A1 Methods for the treatment of insulin resistance and disease states characterized by insulin resistance |
| 09/21/2006 | WO2006098304A1 Novel secretory protein derived from pituitary cell and use of the same |
| 09/21/2006 | WO2006097970A1 Use of inhibitors of steroid (testosterone) activity (i. a. estrogens) or antiandrogens) for treatment of substance correlated disorders like drug abuse |
| 09/21/2006 | WO2005112897A3 Immediate release pharmaceutical tablets with height greater than width |
| 09/21/2006 | US20060211764 Cell activator, process for producing cell activator and apparatus therefor |
| 09/21/2006 | US20060211664 Method for treating erectile dysfunction and increasing libido in men |
| 09/21/2006 | US20060211663 Low dose estrogen interrupted hormone replacement therapy |
| 09/21/2006 | US20060211661 24 hydroxyvitamin d, analogs and uses thereof |
| 09/21/2006 | US20060211622 Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof |
| 09/21/2006 | US20060211607 Somatostatin-dopamine chimeric analogs |
| 09/21/2006 | US20060211602 Use of alanyl aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors |
| 09/21/2006 | US20060211041 Protein binding to akt2 |
| 09/21/2006 | US20060210550 Angiogenesis inducer |
| 09/21/2006 | CA2601051A1 Use of inhibitors of steroid (testosterone) activity (i. a. estrogens) or antiandrogens) for treatment of substance correlated disorders like drug abuse |
| 09/20/2006 | EP1702920A1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/20/2006 | EP1701714A2 Improved sustained release compositions for pulmonary administration of insulin |
| 09/20/2006 | EP1554253A4 Imidazolium cxcr3 inhibitors |
| 09/20/2006 | EP1443940B1 Pharmaceutical composition based on micronized progesterone, preparation method and uses thereof |
| 09/20/2006 | EP1353916B1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/20/2006 | EP0923582B1 Substituted 6,5-hetero-bicyclic derivatives |
| 09/20/2006 | CN1835950A Imidazopyridine derivatives |
| 09/20/2006 | CN1835937A Novel thiazoline derivatives as selective androgen receptor modulators (SARMS) |
| 09/20/2006 | CN1835917A Therapeutic agents |
| 09/20/2006 | CN1835914A New benzamides as PPAR[upsilon] modulators |
| 09/20/2006 | CN1835762A Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus and insulin resistance |
| 09/20/2006 | CN1835760A Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus and insulin resistance |
| 09/20/2006 | CN1835737A Pharmaceutical formulation for contraception and hormone-replacement therapy |
| 09/20/2006 | CN1275940C New phenylalkyloxy-phenyl derivatives |
| 09/20/2006 | CN1275938C Thyroid hormone receptor atagonists for treating cardiac and metabolic disorders II |
| 09/19/2006 | US7109354 Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| 09/19/2006 | US7109196 1,8 Naphthyridine derivatives and their use to treat diabetes and related disorders |
| 09/19/2006 | US7109184 Phosphate transport inhibitors |
| 09/19/2006 | US7109174 Anticonvulsant derivatives useful for preventing the development of type II diabetes mellitus and syndrome X |
| 09/19/2006 | US7109171 Reducing FSH levels by administering a GnRH antagonist to reduce both plasma FSH and LH levels; treating prostatic intraepithelial neoplasia, pedophilia, infertility, vaginal bleeding; in vitro fertilization and male contraception |
| 09/19/2006 | US7109164 Administering compounds such as 3-[[3,5-dibromo-[4-hydroxy-3-(1-methylethyl)phenoxy]-phenyl]amino]-3-oxopropanoic acid for therapy of obesity, hypercolesterolemia atherosclerosis, depression, osteoporosis, hypothyroidism, goiter, glaucoma, cardiac arrhythmia, congestive heart failure, or a skin disorder |
| 09/19/2006 | US7108871 Isoflavones and saponins in defined ratios, menopause, cancer |
| 09/14/2006 | WO2006095822A1 Sulfonamide compound and pharmaceutical thereof |
| 09/14/2006 | WO2006095150A1 Combination of a silicon containing component and a hormone |
| 09/14/2006 | WO2006094456A1 An extract of styrax linn, the preparation and uses thereof |
| 09/14/2006 | US20060205734 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |